Hyperphosphatemia and Cardiovascular Disease

Cell Therapy in Cardiovascular Disease

  Recently, cell therapy has sparked a revolution in ischemic heart disease that will in the future help clinicians to cure patients. Earlier investigations in animal models and clinical trials have suggested that positive paracrine effects such as neoangiogenesis and anti-apoptotic can improve myocardial function. In this regard the Royan cell therapy center designed a few trials in collaborat...

Hyperphosphatemia

تافعاضلماو تايفولل اًيسيئر اًببس مدلا يف تافسوفلا عافترا ربتعي ةليوط ةدم ذنم تتبث دقلو .نمزلما يولكلا روصقلا ىضرم دنع ضارمأ نم ةافولا رطخ ةدايزو مدلاب تافسوفلا عافترا ينب ام ةقلاعلا حملالما ةلاقلما هذه ضرعتست .يئاعولا سلكتلاو ةيئاعولا بلقلا اهتحضوأ امك ةيئاعولا تاسلكتلل ةيضارملإا ةيلمعلل ةديدلجا يف روفسوفلل زيملما يميظنتلا رودلا ةًرهظم ةثيدلحا ثوحبلا ةيللآا هذه .ةيومدلا ةيعولأل ءاسللما ةيلضعلا ايل...

Association of serum melatonin and albumin with cardiovascular disease

Cardiovascular diseases are a major cause of death worldwide.  Endothelial dysfunction, inflammatory conditions, and oxidative stress at the forefront of the onset and progression of most cardiovascular diseases specificaly coronary heart disease and heart failure. Melatonin is a type of indole neuroendocrine hormone.  It was first found that the regulation of the sleep-wake cycle is regulated...

Hyperphosphatemia and vascular calcification in chronic kidney disease

The role of microRNAs in cardiovascular disease

Cardiovascular disease has become the main factor of death and birth defects in the world. There are some therapeutic structures and drugs for curative and palliative therapy of the disease, but to the aim of accessing reliable therapy or to postpone onset of disease, especially for individuals with heritable coronary artery disease in their pedigree Genetic engineering technologies are making...